In this large retrospective study patients with Ki-67 < 55% are less responsive to platinum based chemotherapy but have a longer survival than patients with Ki-67 > 55%; then Ki-67 < 55% is a positive prognostic factor and a negative predictive factor to platinum based chemotherapy (7).